​Strategic Partners

Guiamark S.A. de C.V.

  • Guiamark partners with Triage in conducting primary research with key thought leaders, hospital administrator and payers In Brazil, Mexico and other Latin American countries


Russell Becker

  • A healthcare technology health economics and outcomes research group.
  • Partners with Triage on economic and evidence based services

Senior Consultant Advisory Team


John Proach
John is an experienced reimbursement specialist providing strategic planning and tactical implementation for pharmaceutical products, medical devices and diagnostics. He has 25 + years of experience in health care holding various positions in product marketing and management at companies such as Warner Lambert and the Hospital Satellite Network. At Pearson Professional he was the Executive Vice President for Churchill Communications and was instrumental in establishing Churchill Health Economics group.

He has developed and implemented numerous global reimbursement strategies for pharmaceutical and medical device products including value strategy programs demonstrating economic value for inpatient technologies.  He has petitioned Medicare for new technology add-on payments and sponsored applications for new procedure codes and created the Value Demonstrator concept for creating and validating value messages for negotiation support efforts.

He holds a BS degree in education and an MS degree in business from New York University.

Kathryn Cromer
Kathryn is an experienced market access researcher and project manager having worked with consultancy companies such as Quintiles Consulting and Market Access Solutions.  She has managed numerous global pricing, market access and reimbursement projects for biopharmaceutical and medical device companies.

Kathryn is a clinical coding specialist with 15 years of experience certified by AHIMA and has conducted inpatient and outpatient data analyses supporting evidence development and economic modeling strategies. She has conducted procedure coding assessments for companies validating provider and payer payment pathways.

She holds a BA and MS degree in public policy from the University of Pennsylvania.​

John Long

John has a distinguished career in medicine, pharmacology and consulting to CMS and developers of new technology since being awarded a PhD in pharmacology by the University of Missouri in 1973. In addition, he holds an MD in family practice, also from University of Missouri and an MBA from Columbia. 

Most recently he was a Medical Director for the Disease Management division of McKesson Health Solutions responsible for high cost/high risk chronic condition enrollees, improvement of self-reliance, reduction of unnecessary utilization, clinical condition care plan compliance, adherence to national guidelines and improved clinical outcomes.

At the CMS, he was a Medicare coverage strategist and pricer for all pharmaceuticals in the hospital outpatient (HOPPS) arena.  He reviewed new drug applications  for compliance with Medicare regulatory and statutory authorities, providing  recommendations for beneficiary co-payment amounts, pass-through payments, hospital acquisition costs, APC bundling and Medicare payment rates.  He is the creator of the “single drug pricing” system adopted and implemented by CMS for Medicare drug coverage and reimbursement nationwide.


Jonathan Tierce
​With over 30 years of experience in health economics and outcomes research, and consulting for the healthcare industry, Mr. Tierce is one of the pioneers in the field of applied pharmacoeconomics, pharmacoepidemiology and value demonstration.


  • Independent Healthcare Consultant Since leaving IMS in 2010, Mr. Tierce has worked with a number of healthcare technology companies and consultancies developing strategies for evidence development and communicating value to support innovative medical technologies. 
  • General Manager, Global Health Economics and Outcomes Research at IMS Consulting. Led a global team of 175 professionals that supported the growing need for real-world evidence of the clinical and economic value of the range of diagnostic and treatment interventions in advancing health.
  • Cofounder and Principal of ValueMedics Research LLC, which IMS acquired in March 2007. Assisted clients by identifying appropriate, customized strategies and tactics for market-facing products with respect to access challenges, value propositions and evidence-based demonstrations of value.
  • Vice President of Health Economics and founder and General Manager of Churchill Health Economics at Churchill Communications North America, Inc.
  • Founding Director of the Health Economics Business Unit at State and Federal Associates, Inc.


He has published in such journals as Value in Health, Pharmacoeconomics, the Journal of Managed Care Pharmacy, Archives of Internal Medicine, Medical Care, the American Journal of Psychiatry, Clinical Transplant, the Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, and others.

Quoted publications such as: The Wall Street Journal, The Financial Times, and the Associated Press, among others. 

Education:  Advanced to candidacy for a Ph.D. in political science and received post-graduate training in econometrics and experimental design at the University of California, Los Angeles, where he also earned his M.A. and B.A. (cum laude).


Mark Altenburger
Mark has almost 30 years of sales and marketing experience in the pharmaceutical and medical device industries with Pfizer, Pharmacia, Ethicon and Q-Med.  At Pharmacia he held a number of key management positions including the position of global marketing director for the ophthalmic franchise launching several products in Europe and Japan. 

He was global director at Q-Med overseeing all development and marketing aspects increasing the value over $20M in 2 years. He is an experienced trainer adhering to the Kilpatrick method with years of experience as a sales trainer, a sales training manager, and eventually helped create, staff and initiate a training department.  His experience includes conducting payer negotiations programs and workshops developing access tactics, objection handlers and creating best practice initiatives for US and EU affiliates.

As Vice President of Sales and Marketing he has been involved in many diverse product introductions including; pain management, epilepsy and web based services for key physician associations. Most recently he held a key management and advisory position in several medical device startup companies.

Mark holds undergraduate and graduate degrees in business administration from Morhead State University.

Competency 

  • Our senior team consists of industry professionals, healthcare providers, and policy directors with years of experience developing and executing strategic solutions for healthcare technology companies. 


Depth of Experience

  • Our group is skilled and experienced in business, clinical, medical and policy allowing for an efficient and effective approach.


Professionally Linked  

  • Collectively we have established an enviable network of healthcare policy experts, payers and providers that allows us to obtain and validate insights.


Custom Solutions

  • Clients value our personalized approach in addressing their unique challenges.  We see each of our clients’ challenges as unique and requiring adapted solutions. 


Global Reach

  • We address global solutions through our affiliation with our strategic partners in Europe and Latin America.